Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of August 24, 2026, GKOS trades at $183.76 with a market cap of $10.91B and a P/E ratio of -56.37. GKOS moved +0.00% today. Year to date, GKOS is +63.75%; over the trailing twelve months it is +105.91%. Its 52-week range spans $73.16 to $191.62. Analyst consensus is strong buy with an average price target of $190.46. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Glaukos Corporation (GKOS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GKOS moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $183.76 |
| Market Cap | $10.91B |
| P/E Ratio | -56.37 |
| EPS | $-3.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $191.62 |
| 52-Week Low | $73.16 |
| Volume | 348.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $612.84M |
| Net Income | $-188.05M |
| Gross Margin | 60.70% |
14 analysts cover GKOS: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $190.46.